Prospective Longitudinal Evaluation of Point-of-Care Lung Ultrasound in Critically Ill Patients With Severe COVID-19 Pneumonia.


Journal

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 03 07 2020
accepted: 05 07 2020
pubmed: 17 8 2020
medline: 4 3 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

To perform a prospective longitudinal analysis of lung ultrasound findings in critically ill patients with coronavirus disease 2019 (COVID-19). Eighty-nine intensive care unit (ICU) patients with confirmed COVID-19 were prospectively enrolled and tracked. Point-of-care ultrasound (POCUS) examinations were performed with phased array, convex, and linear transducers using portable machines. The thorax was scanned in 12 lung areas: anterior, lateral, and posterior (superior/inferior) bilaterally. Lower limbs were scanned for deep venous thrombosis and chest computed tomographic angiography was performed to exclude suspected pulmonary embolism (PE). Follow-up POCUS was performed weekly and before hospital discharge. Patients were predominantly male (84.2%), with a median age of 43 years. The median duration of mechanical ventilation was 17 (interquartile range, 10-22) days; the ICU length of stay was 22 (interquartile range, 20.2-25.2) days; and the 28-day mortality rate was 28.1%. On ICU admission, POCUS detected bilateral irregular pleural lines (78.6%) with accompanying confluent and separate B-lines (100%), variable consolidations (61.7%), and pleural and cardiac effusions (22.4% and 13.4%, respectively). These findings appeared to signify a late stage of COVID-19 pneumonia. Deep venous thrombosis was identified in 16.8% of patients, whereas chest computed tomographic angiography confirmed PE in 24.7% of patients. Five to six weeks after ICU admission, follow-up POCUS examinations detected significantly lower rates (P < .05) of lung abnormalities in survivors. Point-of-care ultrasound depicted B-lines, pleural line irregularities, and variable consolidations. Lung ultrasound findings were significantly decreased by ICU discharge, suggesting persistent but slow resolution of at least some COVID-19 lung lesions. Although POCUS identified deep venous thrombosis in less than 20% of patients at the bedside, nearly one-fourth of all patients were found to have computed tomography-proven PE.

Identifiants

pubmed: 32797661
doi: 10.1002/jum.15417
pmc: PMC7436430
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-456

Informations de copyright

© 2020 American Institute of Ultrasound in Medicine.

Références

CMAJ. 2020 Apr 14;192(15):E399
pubmed: 32234724
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
Allergy. 2020 Jul;75(7):1564-1581
pubmed: 32396996
Am J Respir Crit Care Med. 2018 Aug 1;198(3):398-401
pubmed: 29557671
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Chest. 2012 Oct;142(4):965-972
pubmed: 22700780
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Ultrasound Med. 2020 Jul;39(7):1413-1419
pubmed: 32227492
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Chest. 2008 Jul;134(1):117-25
pubmed: 18403664
Intensive Care Med. 2020 Jul;46(7):1445-1448
pubmed: 32367169
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Radiol Med. 2020 May;125(5):514-516
pubmed: 32350796
J Ultrasound Med. 2020 Jul;39(7):1459-1462
pubmed: 32198775
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Anaesthesia. 2020 Aug;75(8):1096-1104
pubmed: 32275766
Clin Chim Acta. 2020 Jun;505:172-175
pubmed: 32156607
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Crit Care Med. 2012 Jul;40(7):2064-72
pubmed: 22584759
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Radiology. 2020 Jun;295(3):E6
pubmed: 32167853
Chest. 2011 Mar;139(3):538-542
pubmed: 21030490
Crit Care. 2020 Jun 2;24(1):275
pubmed: 32487122
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Echocardiography. 2020 Apr;37(4):625-627
pubmed: 32239532
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32269100
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
Crit Care Med. 2018 Jul;46(7):e707-e714
pubmed: 29601314
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Acad Emerg Med. 2000 Feb;7(2):120-6
pubmed: 10691069
Crit Care Med. 2007 Aug;35(8):1837-43; quiz 1852
pubmed: 17581483
Ultrasound Med Biol. 2020 Jul;46(7):1821-1826
pubmed: 32327199
J Ultrasound Med. 2013 Jan;32(1):115-20
pubmed: 23269716
Intensive Care Med. 2020 May;46(5):849-850
pubmed: 32166346
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2776-2780
pubmed: 32196627
Radiol Cardiothorac Imaging. 2020 Apr 06;2(2):e204001
pubmed: 33779627
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Lancet Respir Med. 2020 May;8(5):e27
pubmed: 32203708
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Heart Fail Clin. 2019 Apr;15(2):297-303
pubmed: 30832819
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
Crit Care. 2020 Jun 2;24(1):274
pubmed: 32487231
Radiol Med. 2020 Apr;125(4):365-373
pubmed: 32239472
Invest Radiol. 2020 Jun;55(6):332-339
pubmed: 32134800
Crit Ultrasound J. 2016 Dec;8(1):8
pubmed: 27496127
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Ultrasound J. 2020 Apr 21;12(1):22
pubmed: 32318891
J Infect. 2020 Apr;80(4):394-400
pubmed: 32109443
Am J Respir Crit Care Med. 2011 Feb 1;183(3):341-7
pubmed: 20851923
Crit Care. 2020 Apr 28;24(1):174
pubmed: 32345353
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601

Auteurs

Abdulrahman Alharthy (A)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Fahad Faqihi (F)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Mohamed Abuhamdah (M)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Alfateh Noor (A)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Nasir Naseem (N)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Abdullah Balhamar (A)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Ahad Alhassan Al Saud Bin Abdulaziz Al Saud (AAASBA)

Emergency Department, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Peter G Brindley (PG)

Critical Care Department, Alberta Health Care Services, Edmonton, Alberta, Canada.

Ziad A Memish (ZA)

Research and Innovation Center, King Saud Medical City-Ministry of Health, College of Medicine, Al Faisal University Riyadh, Saudi Arabia.

Dimitrios Karakitsos (D)

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.
Department of Medicine, University of South Carolina School of Medicine, Columbia, South Carolina, USA.

Michael Blaivas (M)

Department of Medicine, University of South Carolina School of Medicine, Columbia, South Carolina, USA.
Department of Emergency Medicine, St Francis Hospital, Columbus, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH